Serum erythropoietin: a useful biomarker for coronary collateral development and potential target for therapeutic angiogenesis among the patients with coronary chronic total occlusion

References

• Alioglu E, Ercan E, Sonmez Tamer G, et al. (2011). Decreased circulatory erythropoietin in hyperacute phase of myocardial ischemia. Int J Cardiol 146:e49–52
   PubMed Web of Science ®Google Scholar
• Andreotti F, Agati L, Conti E, et al. (2009). Update on phase II studies of erythropoietin in acute myocardial infarction. Rationale and design of Exogenous erythroPoietin in Acute Myocardial Infarction: New Outlook aNd Dose Association Study (EPAMINONDAS). J Thromb Thrombolysis 28:489–95
   PubMed Web of Science ®Google Scholar
• Chua S, Leu S, Lin YC, et al. (2011). Early erythropoietin therapy attenuates remodeling and preserves function of left ventricle in porcine myocardial infarction. J Investig Med 59:574–86
   PubMed Web of Science ®Google Scholar
• Doue T, Ohtsuki K, Ogawa K, et al. (2008). Cardioprotective effects of erythropoietin in rats subjected to ischemia -- reperfusion injury: assessment of infarct size with 99mTc-annexin V. J Nucl Med 49:1694–700
   PubMed Web of Science ®Google Scholar
• Ferrario M, Arbustini E, Massa M, et al. (2011). High-dose erythropoietin in patients with acute myocardial infarction: a pilot, randomised, placebo-controlled study. Int J Cardiol 147:124–31
   PubMed Web of Science ®Google Scholar
• Fisher JW. (2010). Landmark advances in the development of erythropoietin. Exp Biol Med (Maywood) 235:1398–411
   PubMed Web of Science ®Google Scholar
• Fleisch M, Billinger M, Eberli FR, et al. (1999). Physiologically assessed coronary collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease. Circulation 100:1945–50
   PubMed Web of Science ®Google Scholar
• Imazuru T, Matsushita S, Hyodo K, et al. (2009). Erythropoietin enhances arterioles more significantly than it does capillaries in an infarcted rat heart model. Int Heart J 50:801–10
   PubMed Web of Science ®Google Scholar
• Kawachi K, Iso Y, Sato T, et al. (2012). Effects of erythropoietin on angiogenesis after myocardial infarction in porcine. Heart Vessels 27:79–88
   PubMed Web of Science ®Google Scholar
• Lipsic E, Schoemaker RG, van der Meer P, et al. (2006). Protective effects of erythropoietin in cardiac ischemia: from bench to bedside. J Am Coll Cardiol 48:2161–7
   PubMed Web of Science ®Google Scholar
• Martin-Yuste V, Barros A, Leta R, et al. (2012). Factors determining success in percutaneous revascularization of chronic total coronary occlusion: multidetector computed tomography analysis. Rev Esp Cardiol 65:334–40
   PubMed Web of Science ®Google Scholar
• Mastromarino V, Volpe M, Musumeci MB, et al. (2011). Erythropoietin and the heart: facts and perspectives. Clin Sci (Lond) 120:51–63
   PubMed Web of Science ®Google Scholar
• Najjar SS, Rao SV, Melloni C, et al. (2011). Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. JAMA 305:1863–72
   PubMed Web of Science ®Google Scholar
• Nakamura R, Takahashi A, Yamada T, et al. (2009). Erythropoietin in patients with acute coronary syndrome and its cardioprotective action after percutaneous coronary intervention. Circ J 73:1920–6
   PubMed Web of Science ®Google Scholar
• Namiuchi S, Kagaya Y, Ohta J, et al. (2005). High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention. J Am Coll Cardiol 45:1406–12
   PubMed Web of Science ®Google Scholar
• Ott I, Schulz S, Mehilli J, et al. (2010). Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial. Circ Cardiovasc Interv 3:408–13
   PubMed Web of Science ®Google Scholar
• Ozawa T, Toba K, Suzuki H, et al. (2010). Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction – randomized controlled pilot trial of EPO/AMI-1 study. Circ J 74:1415–23
   PubMed Web of Science ®Google Scholar
• Sahinarslan A, Yalcin R, Kocaman SA, et al. (2011). The relationship of serum erythropoietin level with coronary collateral grade. Can J Cardiol 27:589–95
   PubMed Web of Science ®Google Scholar
• Stein A, Knodler M, Makowski M, et al. (2010). Local erythropoietin and endothelial progenitor cells improve regional cardiac function in acute myocardial infarction. BMC Cardiovasc Disord 10:43--52
   PubMed Web of Science ®Google Scholar
• Suh JW, Chung WY, Kim YS, et al. (2011). The effect of intravenous administration of erythropoietin on the infarct size in primary percutaneous coronary intervention. Int J Cardiol 149:216–20
   PubMed Web of Science ®Google Scholar
• Taniguchi N, Nakamura T, Sawada T, et al. (2010). Erythropoietin prevention trial of coronary restenosis and cardiac remodeling after ST-elevated acute myocardial infarction (EPOC-AMI): a pilot, randomized, placebo-controlled study. Circ J 74:2365–71
   PubMed Web of Science ®Google Scholar
• Voors AA, Belonje AM, Zijlstra F, et al. (2010). A single dose of erythropoietin in ST-elevation myocardial infarction. Eur Heart J 31:2593–600
   PubMed Web of Science ®Google Scholar
• Werner GS, Ferrari M, Heinke S, et al. (2003). Angiographic assessment of collateral connections in comparison with invasively determined collateral function in chronic coronary occlusions. Circulation 107:1972–7
   PubMed Web of Science ®Google Scholar
• Westenbrink BD, Lipsic E, van der Meer P, et al. (2007). Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. Eur Heart J 28:2018–27
   PubMed Web of Science ®Google Scholar
• Westenbrink BD, Ruifrok WP, Voors AA, et al. (2010). Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure. Cardiovasc Res 87:30–9
   PubMed Web of Science ®Google Scholar